FOXBOROUGH, Mass.--(BUSINESS WIRE)--Cyberkinetics Neurotechnology Systems, Inc. (OTCBB: CYKN; “Cyberkinetics”; “Company”), a medical device company focused on developing novel implantable products to treat neurological diseases and injuries of the central nervous system, announced that the Company’s Andara™ OFS™ Therapy for acute spinal cord injury has been selected for inclusion in the 2007 Advanced Medical Technology Association’s (“AdvaMed”) “Progress You Can See” events on Capitol Hill. Cyberkinetics is one of several companies that will be represented at the event by a physician and patient pair.
